Myocardial inotropic reserve: An old twist that constitutes a reliable index in the modern era of heart failure
Current national and international guidelines, including those of the European Society of Cardiology, recognize that the assessment of prognosis should be a part of the standard management for patients with chronic heart failure (CHF). However, these same guidelines recognize the inherent difficulty...
Main Authors: | Fragkiskos Parthenakis, Spyridon Maragkoudakis, Maria Marketou, Alexandros Patrianakos, Evaggelos Zacharis, Panos Vardas |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-09-01
|
Series: | Hellenic Journal of Cardiology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1109966616303086 |
Similar Items
-
Use of Inotropic Agents in Treatment of Systolic Heart Failure
by: Sohaib Tariq, et al.
Published: (2015-12-01) -
Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial
by: Pietro Di Santo, et al.
Published: (2021-08-01) -
DOBUTAMINE USAGE IN CARDIOLOGICAL PRACTICE
by: M. Yu. Giljarov
Published: (2016-01-01) -
Dobutamine-sparing versus dobutamine-to-all strategy in cardiac surgery: a randomized noninferiority trial
by: Rafael Alves Franco, et al.
Published: (2021-01-01) -
Norepinephrine and dobutamine improve cardiac index equally by supporting opposite sides of the heart in an experimental model of chronic pulmonary hypertension
by: Janus Adler Hyldebrandt, et al.
Published: (2021-06-01)